The hepatitis C virus has different types or virus strains called genotypes. Each genotype has a unique genetic makeup; some have subtypes.

Do you know the benefits of successful hepatitis C treatment, along the risks associated with not trying treatment?

The U.S. FDA announced the approval of Mavyret, the first treatment for all hepatitis C genotypes in children ages 12 to 17.

A story about hepatitis C and hope in Bosnia

Hemochromatosis is a condition that can be associated with hepatitis C. Hemochromatosis is a potentially dangerous condition.

Hepatitis Awareness Month, observed in May, is nearly over. It’s the perfect time to talk about the liver.

HRSA’s Ryan White HIV/AIDS Program observes Hepatitis Awareness Month and highlights some efforts to eliminate hepatitis C coinfection.

If you live with liver disease, you need knowledge about how your liver works, so you can give it lots of support, and live longer...

For Hepatitis Awareness Month, HHS launched a new project- Mapping Hepatitis Elimination in Action along with key messaging graphics.

The U.S. FDA approved hepatitis C treatment Mavyret for children from ages 12 to 17 with all genotypes.